Accretion Pharmaceuticals logo

Accretion Pharmaceuticals financials and balance sheet

NSE: ACCPLPharmaceuticals & Biotechnology

Last close ₹182.10down ₹7.20 (3.80%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹189.30.

52-week range of traded prices to 23 Oct 2026
₹54.60Low, 27 Oct 2025₹220.00High, 30 Sep 2026
Market cap
₹202 Cr
P/E
20.9
P/B
3.7
Dividend yield
Nonein the last 12 months
ROE
27.6%
Debt to equity
0.23
Volume, NSE
7,200100.0% delivered

2 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Accretion Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹90 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue90
  2. Materials and goods−65
  3. Employee costs−4.5
  4. Other expenses−5.0
  5. Operating profit15
  6. Depreciation−1.2
  7. Other income+0.2
  8. Finance costs−0.8
  9. Profit before tax13
  10. Tax−3.4
  11. Net profit9.7

What the company owns

  • Inventory₹28 Cr
  • Receivables₹22 Cr
  • Plant, investments and other assets₹22 Cr
  • Cash and bank₹4 Cr

What pays for it: net worth and liabilities

  • Net worth₹55 Cr
  • Borrowings₹12 Cr
  • Owed to suppliers₹6 Cr
  • Other liabilities₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March.Accretion Pharmaceuticals half-yearly results

₹ croreMar 2025Filed 11 JunMar 2026Filed 8 May
Revenue from operations57.489.6
45.574.7
Materials and goods bought39.965.2
Employee costs3.74.5
Other expenses1.95.0
Operating profit before depreciation11.915.0
Operating margin20.7%16.7%
Materials, % of revenue69.6%72.7%
Employee costs, % of revenue6.4%5.0%
Other expenses, % of revenue3.3%5.6%
Depreciation and amortisation0.81.2
Operating profit after depreciation11.113.7
Other income0.10.2
Finance costs1.40.8
Profit before tax9.813.1
3.03.4
Net profit6.89.7
Net margin11.8%10.8%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2025Filed 11 JunMar 2026Filed 8 May
15.354.7
Share capital8.211.1
Reserves7.143.6
14.112.3
23.220.8
1.41.1
Total assets39.976.7
6.316.1
33.560.6
Net debt14.18.3
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2025Filed 11 JunMar 2026Filed 8 May
5.8−14.6
7.7−11.3
−4.3−26.4
Receivables−5.9−10.7
Inventories−6.1−7.8
Payables1.0−1.8
Other working capital6.7−6.1
Tax paid−1.9−3.3
Capital spending1.68.5
Free cash flow4.2−23.2
Cash from investing−1.6−8.5
−4.327.1
Dividends paid0.00.0
Shares issued3.029.8
Net change in cash0.04.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2025Filed 11 JunMar 2026Filed 8 May
Earnings per share₹8.48₹9.03
Diluted earnings per share₹8.48₹9.03
Book value per share₹18.71₹49.22
Shareholder yield–−42.1%
Market cap at the year end (₹ crore)–70.6
RatioMar 2025Filed 11 JunMar 2026Filed 8 May
Revenue growth–56.2%
Operating profit growth–25.8%
Net profit growth–42.3%
Earnings per share growth–6.5%
44.4%27.6%
–−16.8 pts
From the net margin–−4.0 pts
From asset turnover–2.8 pts
From borrowing–−15.7 pts
Return on capital employed37.8%20.5%
Cash conversion85.7%−151.2%
Interest cover7.716.2
Debt to equity0.920.23
Receivable days7491
Inventory days188159
Payable days6932
Cash conversion cycle, days193218
Working capital days148192
Asset turnover1.441.54
Assets per rupee of net worth2.611.66
Sales per rupee of plant9.426.78
Capital spending to depreciation2.087.05

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
16.6%
Cash from operations against operating profit
−97.8%
Measure3 years
Return on equity, average36.0%
Return on capital employed, average29.1%
Operating margin, average18.7%
Net margin, average11.3%
Asset turnover, average1.49
Cash conversion cycle, days, average206
Interest cover, average12.0
Debt to equity, average0.57

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−14.6
Cash from investing−8.5
Cash from financing27.1
Capital spending8.5
Dividends paid0.0
Shares issued for cash29.8
Borrowings raised0.0
Borrowings repaid1.8

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points–35.88
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−25.57
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–5.10
Effective tax ratePublished threshold 17.16 per cent30.4226.11
Tax charged less tax paid, % of profitOur threshold 10 percentage points11.400.59
A threshold marked as ours has no published figure; it is the line we read the check against.